News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) 1/27/2015
StemCells (STEM) Posts Letter To Shareholders 1/26/2015
Claritas Genomics Caps Landmark Year With New Investment After Launching Novel Diagnostic Tests For Childhood Disorders And Advancing The Application Of Next-Gen Sequencing In Routine Clinical Care 1/26/2015
Cardio3 BioSciences Announces Agenda And Webcast For 2015 NYC Investor Day 1/26/2015
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China 1/23/2015
Alder Biopharmaceuticals Inc. Announces Exercise In Full Of Option To Purchase Additional Shares 1/23/2015
Auspex Pharmaceuticals (ASPX) Announces Pricing Of Follow On Offering 1/23/2015
Radius (RDUS) Announces Pricing Of Public Offering 1/23/2015
Otonomy, Inc. (OTIC) Announces Pricing Of Follow-On Public Offering 1/23/2015
Zafgen (ZFGN) Announces Pricing Of Public Offering Of Common Stock 1/23/2015
Vitae Pharmaceuticals, Inc. (VTAE) Announces Pricing Of Follow-On Public Offering Of Common Stock 1/23/2015
BioMarin (BMRN) Announces Underwriters' Full Exercise Of Option To Purchase Additional Shares 1/23/2015
Cord Blood America, Inc. Announces Preliminary Proxy Filing And Details Why A "YES" Vote To Increase Authorized Shares Is Requested 1/23/2015
Verastem, Inc. (VSTM) Announces Pricing Of Public Offering Of Common Stock 1/23/2015
Puma Biotechnology (PBYI) Announces Underwriters’ Full Exercise Of Option To Purchase Additional Shares 1/23/2015
Mallinckrodt plc Announces Share Repurchase Program 1/23/2015
Merck & Co. (MRK), On Behalf Of Its Wholly Owned Subsidiary, Cubist Pharmaceuticals, Inc. (CBST), Announces Tender Offer For Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes Due 2018 And 1.875% Convertible Senior Notes Due 2020 1/23/2015
Pivotal Therapeutics Inc.: Year In Review And CEO Update 1/23/2015
Beckman Coulter, Inc. (BEC) Webinar Presents How Stem Cells Speak With Immune Cells 1/22/2015
New Contestant Named in Best Hair in Biopharma As Race for Crown Heats Up 1/22/2015
Otonomy, Inc. (OTIC) Announces Launch Of Follow-On Public Offering 1/22/2015
BioMarin (BMRN) Announces Public Offering Of Common Stock 1/22/2015
Auspex Pharmaceuticals (ASPX) Announces Proposed Public Offering Of Common Stock 1/22/2015
Keryx Biopharmaceuticals (KERX) Announces Pricing Of $110 Million Public Offering Of Common Stock 1/22/2015
Versartis, Inc. (VSAR) Announces Pricing Of Follow-On Offering 1/22/2015
Intrexon Corporation Prices Public Offering Of Common Stock 1/22/2015
Recipharm AB Releases The Lock-Up On 815,000 B-Shares Related To Shares To Be Issued Upon Conversion Of Convertible Bonds 1/22/2015
Shire (SHPGY) Added To Global 100 Sustainability Index 1/22/2015
PhytoTech Medical Limited (ASX:PYL) First Medical Cannabis Company To List On The Australian Stock Exchange 1/22/2015
InspireMD Ltd. Announces Notification of NYSE MKT Listing Deficiency 1/22/2015
Ultimovacs Carries Out NOK 45 Million Share Issue With Canica AS And Sundt AS As The Main Investors 1/22/2015
PTS, Inc Announces Investment Discussion In Biotech Company 1/22/2015
Oculus Innovative Sciences, Inc. (OCLS) Announces Pricing Of Upsized $6.3 Million Underwritten Public Offering 1/21/2015
Zafgen (ZFGN) Announces Proposed Public Offering Of Common Stock 1/21/2015
CollabRx, Inc. Receives NASDAQ Listing Determination; Intends To Request Hearing 1/21/2015
Keryx Biopharmaceuticals (KERX) Announces $100 Million Proposed Public Offering Of Common Stock 1/21/2015
Radius (RDUS) Announces Proposed Public Offering 1/21/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Grants Stock Options Under Inducement Program 1/21/2015
Ablynx (ABLYF) Announces Warrant Exercise 1/21/2015
HEALTHSOUTH Announces Pricing Of $400 Million Senior Notes Offering 1/21/2015
Intrexon Corporation Announces Proposed Public Offering Of Common Stock 1/21/2015
Arena Pharmaceuticals, Inc. (ARNA) Announces Public Offering Of Common Stock 1/21/2015
NanoViricides, Inc. (NNVC.PK)'s Executive Officers Report Insider Purchases Of Common Stock 1/21/2015
Endo International (ENDP) Announces Pricing of Private Offering Of Senior Notes 1/21/2015
Recipharm AB Releases The Lock-Up On 1.3 Million B-Shares Related To Shares To Be Issued Upon Conversion Of Convertible Bonds 1/21/2015
Arena Pharmaceuticals, Inc. (ARNA) Announces Agreement To Sell Common Stock 1/21/2015
Alnylam Pharmaceuticals (ALNY) Prices Public Offering Of Common Stock 1/21/2015
NovaBay Pharmaceuticals, Inc. (NBY) Management And Key Industry Opinion Leaders To Hold Investment Community Conference Call Today, January 21st, 2015, At 12:00 P.M. ET 1/21/2015
Seattle Genetics, Inc. (SGEN) To Host Conference Call And Webcast Discussion Of Fourth Quarter And Year 2014 Financial Results On February 10, 2015 1/21/2015
Stevia First Corp. Provides Letter To Shareholders 1/21/2015
Puma Biotechnology (PBYI) Announces Proposed Public Offering 1/21/2015
Verastem, Inc. (VSTM) Announces Proposed Public Offering Of Common Stock 1/21/2015
Minerva Neurosciences, Inc. (NERV) Announces $15 Million Debt Facility With Oxford Finance LLC And Silicon Valley Bank 1/20/2015
Endo International (ENDP) Announces Proposed Private Offering Of Senior Notes 1/20/2015
NeuroDerm Ltd. (NDRM) Announces Extraordinary General Meeting Of Shareholders For Ratification Of Election Of External Directors And Adoption Of Compensation Policy 1/20/2015
Versartis, Inc. (VSAR) Announces Proposed Offering Of Common Stock 1/20/2015
Raptor Pharmaceutical Inc. (RPTP) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/20/2015
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 1/20/2015
Vitae Pharmaceuticals, Inc. (VTAE) Launches Proposed Follow-On Public Offering Of Common Stock 1/20/2015
HEALTHSOUTH Announces Launch Of $300 Million Senior Notes Offering 1/20/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 1/20/2015
ErgoMed 2014 Business Update 1/20/2015
Regado Biosciences, Inc. (RGDO) And Tobira Therapeutics Inc. Merger Agreement Conference Call Set For 8:30 A.M. EST Today, Jan. 20 1/20/2015
Microvi Biotech Secures Investment From SKion 1/20/2015
Becton, Dickinson and Company (BDX) Announces Webcast Of Annual Meeting of Shareholders 1/19/2015
China's State Council Announces Official $6.5 Billion VC Fund 1/19/2015
Horizon Discovery Group plc Trading Update 1/19/2015
NovaBiotics Ltd Raises £5.0 Million In A Private Placement From Woodford Investment Management 1/19/2015
Xenetic Biosciences To Hold Business Update Conference Call January 20th 1/19/2015
Biotech IPOs Up 22% Since "Bubble" Year of 2000, Shows New Data 1/19/2015
J.P. Morgan: bluebird bio (BLUE) Soars On CEO's Sickle Cell Data 1/16/2015
J.P. Morgan: Juno Therapeutics (JUNO) Touts 10 New Drugs for Six Diseases, Loves New CAR-T Platform 1/16/2015
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 1/16/2015
Valeant (VRX) Announces Redemption Of All Of The Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 1/16/2015
ALPHAEON Corporation Closes Series A Preferred Stock Financing In A Transaction Led By Longitude Capital Management Co., LLC. 1/16/2015
CASI Pharmaceuticals  (ENMD) Highlights 2014 Accomplishments And 2015 Milestones 1/16/2015
ERYtech Pharma Announces Its Financial Calendar For 2015 1/16/2015
Flamel Technologies (FLML) Update To Shareholders On Neostigmine Methylsulfate 1/16/2015
BioMarin (BMRN) Announces Completion Of Tender Offer For ProSensa Holding N.V. (RNA)'s Shares And Commences Subsequent Offering Period 1/15/2015
VG Life Sciences, Inc. (VGLS) Q4 2014 Shareholder Update Letter 1/15/2015
Adamis Pharmaceuticals (ADMP) Announces Closing Of Public Offering Of Common Stock And Exercise Of Over-Allotment Option In Full 1/15/2015
Immucor To Host Debt Investor Conference Call On Thursday, January 22, 2015 1/15/2015
Abbott Laboratories (ABT) Announces Results Of Tender Offer And Consent Solicitation For CFR International Spa 5.125% Senior Notes Due 2022 1/15/2015
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 1/15/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 1/15/2015
J.P. Morgan: AstraZeneca PLC (AZN) CEO Says He's Not Worried About Pricing Pressure 1/15/2015
Cempra Pharmaceuticals, Inc. (CEMP) Announces Full Exercise Of Additional Share Option And Completion Of The Public Offering Of Common Stock 1/14/2015
CytoSorbents, Inc. Announces Closing Of Public Offering 1/14/2015
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 1/14/2015
Alcobra (ADHD) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Over-Allotment Option 1/14/2015
Debiopharm Diagnostics Leads Investment Round In GenePOC With Emerillon Capital 1/14/2015
IDEXX Laboratories, Inc. (IDXX) Instrument Placement Momentum Reinforces Strong Organic Revenue Growth Outlook 1/14/2015
J.P. Morgan: Valeant (VRX) Investors Should Expect "Small and Medium Sized" Deals in 2015, Says CFO 1/13/2015
Merck & Co. (MRK) Issues Updates on Strategic Initiatives, Opportunities 1/13/2015
J.P. Morgan Breaking News: Medtronic, Inc. (MDT) to Return 50% of Cash Flow to Shareholders, Will Close Covidien (COV) Deal in Weeks 1/13/2015
ProSensa Holding N.V. (RNA) Announces Shareholder Approval Of Certain Matters Relating To The BioMarin (BMRN) Tender Offer 1/13/2015
Insmed Incorporated (INSM) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/13/2015
Cubist Pharmaceuticals, Inc. (CBST) Announces Withdrawal Of Listing Of CVRs (CBSTZ) From NASDAQ Global Select Market 1/13/2015
Cardio3 BioSciences To Host Investor & Analyst Day In New York On Friday, January 30, 2015 1/13/2015
MWI Veterinary Supply Announces Postponement Of 2015 Annual Meeting Of Stockholders 1/13/2015
J.P. Morgan: Express Scripts Inc. CEO Said it Will Take On Cancer Drug Pricing Next 1/13/2015
OvaScience (OVAS) Announces Closing Of $132 Million Public Offering Of Common Stock Including Exercise Of Underwriters’ Option To Purchase Additional Shares 1/12/2015
Allergy Therapeutics plc Release: Trading Update 1/12/2015
Skyepharma PLC (SKYEF) Release: Pre-Close Update 1/12/2015
ERYtech Pharma Announces ADR Level 1 Listing In The U.S. 1/12/2015
CARMAT - Financial Agenda 2015 1/12/2015
Invitae Corporation Files Registration Statement For Proposed Initial Public Offering 1/12/2015
Centene Corporation Announces Pricing Of Notes 1/12/2015
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 1/12/2015
Catalyst Pharmaceuticals (CPRX) Provides An Update Of 2015 Goals For Its Product Portfolio 1/12/2015
ReVance Therapeutics, Inc. (RVNC) Defines Clinical Program Milestones And Provides Financial Guidance For 2015 1/12/2015
OncoMed Pharmaceuticals, Inc. (OMED) Pre-Announces 2014 Year-End Cash Balance And Provides 2015 Guidance 1/12/2015
Fate Therapeutics (FATE) Announces Key 2015 Objectives For The Advancement Of Programmed Cellular Therapeutics Pipeline 1/12/2015
Zogenix, Inc. (ZGNX) Provides Business Update 1/12/2015
Vital Therapies, Inc. (VTI) (VTL) Provides Clinical And Regulatory Update 1/12/2015
Advaxis, Inc. Provides 2014 Year-End Review And 2015 Outlook 1/12/2015
Amicus Therapeutics, Inc. (FOLD) Provides Full-Year 2015 Strategic Outlook And Financial Guidance 1/12/2015
Capricor Therapeutics, Inc. Announces $10 Million Private Placement Of Common Stock 1/12/2015
Intercept Pharmaceuticals (ICPT) Provides 2014 Year-End Update And Planned 2015 Milestones 1/12/2015
Five Prime Therapeutics, Inc. (FPRX) Announces Closing Of Public Offering 1/12/2015
MGB Biopharma Limited Continues To Progress Its Truly Novel Anti-Infectives Platform To Tackle Antibiotic Resistance In 2014 1/12/2015
TapImmune Inc. (TPIV) Announces $1,464,000 Million Registered Direct Offering 1/12/2015
ULURU Inc. Provides Business Update 1/12/2015
NeuroVive Pharmaceutical AB: Annual General Meeting Brought Forward To March 30 2015 1/12/2015
BioSpace (DHX) Poll Finds Massive Support for Pfizer (PFE), AbbVie (ABBV) Bid 1/9/2015
Fountain Healthcare's New €85 Million Fund to Create New Jobs in Biotech, Medtech 1/9/2015
Adamis Pharmaceuticals (ADMP) Announces Proposed Public Offering Of Common Stock 1/9/2015
Alcobra (ADHD) Announces Commencement Of Public Offering Of Ordinary Shares 1/9/2015
Otonomy, Inc. (OTIC) Provides Corporate And Product Pipeline Update 1/9/2015
Otonomy, Inc. (OTIC) Files Registration Statement For Proposed Follow-On Public Offering 1/9/2015
Centene Corporation Announces Offering Of Notes 1/9/2015
PureTech Announces $50M In New Funding Round, Bringing Total Raised In Last Four Months To $107M 1/9/2015
Adamis Pharmaceuticals (ADMP) Announces Pricing Of Public Offering Of Common Stock 1/9/2015
Alcobra (ADHD) Prices Public Offering Of Ordinary Shares 1/9/2015
China Biologic Products Adopts Stockholder Rights Plan 1/9/2015
Arrowhead Issues Diligence And Valuation Report On Hemispherx Biopharma (HEB) 1/9/2015
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 1/9/2015
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/9/2015
Macrocure (MCUR) To Host And Webcast Analyst & Investor Day On February 12, 2015 1/9/2015
Addex Therapeutics (ADXN.SW) Completes 2014 With Strong Cash Position And Provides 2015 Strategic Update 1/9/2015
Aptuit LLC To Divest Two Non-Core Sites; Facilitates Reinvestment And Accelerated Growth In Core Area Of Integrated Solutions 1/9/2015
Zivo Bioscience, Inc. Announces Amended Convertible Debt Structure And Continued Support From Primary Lender 1/9/2015
Mylan Inc. (MYL) ex-CEO, Glass Lewis Battle Over Proxy Adviser Power 1/9/2015
Retrophin (RTRX) Provides Corporate Update 1/9/2015
Pacira Pharmaceuticals, Inc. (PCRX) To Host Analyst & Investor Day On Jan. 22 In New York 1/9/2015
Verastem, Inc. (VSTM) Provides Year-End 2014 Update And Outlook For 2015 1/9/2015
Seventure Invests EUR 1 M (USD 1.25 M) In First Investment Round For MaaT Pharma™ 1/9/2015
Avalanche Biotechnologies (AAVL) Prices Public Offering Of $141.6 Million Of Common Stock 1/8/2015
Alder Biopharmaceuticals Inc. Announces Pricing Of Follow-On Offering 1/8/2015
Stemline Therapeutics, Inc. (STML) Prices $59.85 Million Public Offering Of Common Stock 1/8/2015
Stemline Therapeutics, Inc. (STML) Announces Proposed Public Offering Of Common Stock 1/8/2015
CTI BioPharma Announces 2015 Outlook And Recent Drug Portfolio Progress 1/8/2015
Cempra Pharmaceuticals, Inc. (CEMP) Prices Public Offering of Common Stock 1/8/2015
Xenon Pharmaceuticals Inc. Outlines Key Anticipated Milestones For 2015 1/8/2015
XRpro Sciences Announces Completion Of Equity Financing 1/8/2015
DelMar Pharmaceuticals Commences Offer To Exchange Common Stock For Outstanding Warrants 1/8/2015
Regulus Therapeutics, Inc. (RGLS) Announces Key Goals Under Its 'Clinical Map Initiative' For 2015 1/8/2015
Trevi Therapeutics Closes $15 Million Debt Facility Provided By Solar Capital And Square 1 Bank 1/8/2015
Alnylam Pharmaceuticals (ALNY) Launches “Alnylam 2020” Guidance For Advancement And Commercialization Of RNAi Therapeutics 1/8/2015
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2015 1/8/2015
Galena Biopharma  (GALE) Provides 2015 Outlook 1/8/2015
The Medicines Company (MDCO) Prices $350 Million Of Convertible Notes 1/8/2015
Biotech Hedge Fund Manager's Son Shot Him Over Allowance Cut 1/7/2015
Five Prime Therapeutics, Inc. (FPRX) Prices Public Offering Of Common Stock 1/7/2015
Karyopharm Therapeutics (KPTI) Announces Pricing Of Public Offering Of Common Stock 1/7/2015
Synageva BioPharma (GEVA) Announces Pricing Of Public Offering Of Common Stock 1/7/2015
Biotechs To Follow In 2015 Off Fresh Insider Moves 1/7/2015
Eli Lilly (LLY) Provides Update On Strategy And Announces 2015 Financial Guidance 1/7/2015
Halozyme Therapeutics, Inc. (HALO) Provides Agenda Highlights For Analyst And Investor Meeting 1/7/2015
BrainStorm Cell Therapeutics Inc. Announces Receipt Of Approximately $3.1 Million From Warrant Exercises 1/7/2015
Novogen Limited (NVGN) To Conduct Shareholder/Investor Briefing In New York 1/7/2015
Mesa Labs (MLAB) Declares Quarterly Dividend 1/7/2015
Cerus Corporation (CERS) Prices $70.0 Million Public Offering Of Common Stock 1/7/2015
Retrophin (RTRX) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/7/2015
OvaScience (OVAS) Announces Proposed Public Offering Of Common Stock 1/7/2015
Fundamentals Still Strong for Large Cap Biotech, But Headwinds Remain 1/7/2015
Synageva BioPharma (GEVA) Announces A 2.5 Million Share Proposed Public Offering Of Its Common Stock 1/6/2015
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 1/6/2015
Cempra Pharmaceuticals, Inc. (CEMP) Announces Proposed Public Offering Of $100 Million Of Common Stock 1/6/2015
Karyopharm Therapeutics (KPTI) Announces Proposed Public Offering Of Common Stock 1/6/2015
Alder Biopharmaceuticals Inc. Announces Commencement Of Follow-On Offering 1/6/2015
Five Prime Therapeutics, Inc. (FPRX) Announces $75 Million Proposed Public Offering Of Common Stock 1/6/2015
Avalanche Biotechnologies (AAVL) Announces Proposed Public Offering Of Common Stock And Partial Release Of Lock-Up Agreements In Connection Therewith 1/6/2015
CutisPharma Inc. Closes Equity Financing With Ampersand Ventures 1/6/2015
Cerus Corporation (CERS) Announces Proposed Public Offering Of Common Stock 1/6/2015
Relmada Therapeutics To Provide Corporate Update At 2015 Biotech Showcase™ In San Francisco 1/6/2015
Pfizer (PFE) Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference 1/6/2015
Dyadic International, Inc. Extends Debt Maturity Date On Note Payable 1/6/2015
Portola Pharmaceuticals, Inc. Announces Webcast Of Corporate Presentation On January 12, 2015 1/6/2015
AmpliPhi Biosciences Corporation (APHB) Provides Shareholder Update 1/6/2015
The FDA’s Breakthrough Therapy Program By the Numbers 1/5/2015
Protalix Biotherapeutics, Inc. (PLX) Announces New Strategy For Accelerated Growth 1/5/2015
RedHill Biopharma Ltd. (RDHL) Business Outlook And Anticipated Key Milestones For 2015 1/5/2015
Enzymotec Announces An Extraordinary General Meeting Of Shareholders 1/5/2015
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/5/2015
Immune Therapeutics Inc. CEO Issues Letter To Shareholders Highlighting Significant Progress 1/5/2015
Biotech Investors Surge Happily Into New Year, “Frothy” or Not, Says Cowen 1/5/2015
Batu Biologics Releases 2014 Shareholder Letter 1/2/2015
Tianyin Pharmaceutical Co, Inc. Updates on Alliance Discussion 1/2/2015
AVEO Oncology (AVEO)'s Comeback Hits a Snag as Nasdaq Warns It Could be Delisted 1/2/2015



//-->